New anti-inflammation drug may lower heart disease and cancer risks

August 28, 2017

A drug that fights inflammation can reduce the risk of heart attacks and strokes, and possibly lung cancer, in people who have already had one heart attack and are at high risk for another, a new study finds.

heartmonitoring.jpg

Image courtesy of the New York Times.

Researchers outside the study say the findings represent a major milestone — proof of a biologic concept that opens the door to new ways of treating and preventing cardiovascular disease in people who are still at risk despite standard therapies.

But experts also cautioned that potentially fatal side effects of the drug, as well as its high cost, mean it is unlikely to be widely used. Cardiovascular disease is the leading cause of death worldwide and in the United States, where it killed nearly 634,000 people in 2015. Globally, it killed 15 million."


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Lawmakers Reject Amendment to Require Drug Pricing in TV Ads
Are Rebates the New Villain of High Drug Prices?
New Bill Will Propose Mandating Price Transparency in Healthcare

Featured Articles

North Carolina moves into phase 2 of reopening
Medicaid Managed Care Will Save Money – So Why Hasn’t it Happened?
Cost of COVID-19: Telehealth is a life (and cost) saver
Cost of COVID-19: PBMs Advocate for Increased Access to Meds as COVID-19 Rages On
Cost of COVID-19: Blue Cross NC Waives Fees for COVID-19 Treatment
Cost of COVID-19: Steps you can take right now to save on health care costs